Well, the big concern in here is: "concluding phase of the NDA review process, including alignment on the final Illuccix® product label."
Which means they are currently misaligned. I'm hopeful it is something minor.
But the other bit of news out of the meeting was breakthrough designation for Novartis' Lu-PSMA. Which may be good news for Telix too...
Well, the big concern in here is: "concluding phase of the NDA...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.32 |
Change
0.100(0.52%) |
Mkt cap ! $6.465B | |||
| Open | High | Low | Value | Volume |
| $19.30 | $19.50 | $19.08 | $22.36M | 1.160M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3890 | $19.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.34 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |